Check out our most popular compounded medications! Get Started
The Sulfadiazine 400 mg/ml/Trimethoprim 80 mg/ml Equine Oral Liquid is a specially compounded medication designed for oral use in horses. This formulation combines two antibiotics, sulfadiazine and trimethoprim, in a liquid form that is easy to administer. It is particularly beneficial for horses that have difficulty swallowing pills or for those that require a more palatable medication form.
This medication is indicated for the treatment of a range of bacterial infections in horses. It is commonly used to combat respiratory tract infections, such as pneumonia, as well as urinary tract infections, wound infections, and other systemic infections caused by susceptible organisms. The combination of sulfadiazine and trimethoprim works synergistically to inhibit bacterial growth, providing a broad-spectrum antibacterial effect.
Due to its liquid form, this medication is ideal for equine patients that are uncooperative with solid dosage forms or have special needs that make traditional administration methods impractical. The formulation is designed to be both convenient for the caregiver and tolerable for the animal, ensuring that the course of treatment is completed successfully.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Our specially compounded Sulfadiazine/Trimethoprim Equine Oral Liquid is a meticulously prepared medication designed for ease of administration in horses. This formulation combines two potent antibiotics, sulfadiazine and trimethoprim, in a high concentration liquid form, with 400 mg/ml of sulfadiazine and 80 mg/ml of trimethoprim. The liquid dosage form ensures precise dosing and is particularly beneficial for animals that may have difficulty swallowing pills or tablets, such as equines with dental issues or those that are uncooperative with traditional forms of medication.
Sulfadiazine is a sulfonamide antibacterial that interferes with the synthesis of folic acid in bacteria, thereby inhibiting bacterial growth. Trimethoprim works synergistically with sulfadiazine, blocking a different enzyme in the folic acid pathway, leading to a sequential blockade that enhances the antibacterial effects.
The use of this oral liquid formulation allows for flexible dosing tailored to the specific needs of the horse, taking into account factors such as the severity of the infection, the horse's weight, and overall health. It is important to adhere to the prescribed dosage and duration of treatment to ensure the best therapeutic outcome and to reduce the risk of resistance development. As with any antibiotic treatment, it is crucial to monitor the patient for signs of adverse reactions or allergies and to adjust the treatment as necessary under veterinary guidance.
For patients, the palatable nature of the medication facilitates compliance and ease of administration. If you have any questions regarding this formulation or its use in treating specific disease states in equines, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of expert compounding pharmacists is dedicated to providing the highest quality of care and is ready to assist with any inquiries or concerns.
The combination of sulfadiazine and trimethoprim in an equine oral liquid formulation is commonly used to treat bacterial infections in horses, as it combines the antibacterial effects of both drugs to inhibit the growth and multiplication of bacteria. Sulfadiazine is a sulfonamide antibacterial that interferes with the synthesis of folic acid in bacteria, while trimethoprim, a dihydrofolate reductase inhibitor, further blocks the production of tetrahydrofolic acid, which is necessary for bacterial DNA synthesis. This synergistic combination results in a bactericidal effect against a wide range of gram-positive and gram-negative organisms.
When considering the use of this formulation, it is important to be aware of potential drug interactions. Sulfadiazine and trimethoprim can interact with other medications, potentially altering their effects or increasing the risk of adverse reactions. For instance, concurrent use with anticoagulants like warfarin may increase the risk of bleeding due to the displacement of warfarin from plasma proteins by sulfadiazine. Careful monitoring of prothrombin time or INR is advised when these drugs are used together.
Diuretics, particularly thiazides, may increase the incidence of thrombocytopenia associated with sulfonamides. Additionally, the use of sulfadiazine with phenylbutazone, another nonsteroidal anti-inflammatory drug (NSAID), can lead to an increased likelihood of toxicity due to competition for albumin binding sites. Patients receiving this combination should be closely monitored for signs of NSAID toxicity.
Concomitant use of sulfadiazine/trimethoprim with methotrexate, a chemotherapeutic and immunosuppressive agent, can lead to increased methotrexate toxicity due to the displacement of methotrexate from plasma proteins and decreased renal clearance. This combination should be avoided or used with caution, and if necessary, methotrexate plasma levels should be monitored.
Trimethoprim may enhance the effects of antidiabetic medications, which could lead to hypoglycemia. Patients on oral hypoglycemic agents or insulin should be closely monitored for signs of low blood sugar, and dosage adjustments may be necessary. Additionally, trimethoprim can increase potassium levels when used with ACE inhibitors, angiotensin receptor blockers (ARBs), or potassium-sparing diuretics, potentially leading to hyperkalemia. Serum potassium should be monitored in patients receiving this combination.
It is also important to note that sulfadiazine can crystallize in the urine, particularly in acidic and concentrated urine, leading to kidney damage. Adequate hydration is important to prevent this complication. Patients with renal impairment should use this medication with caution, and renal function should be monitored during treatment.
Lastly, this formulation should not be used in animals with known hypersensitivity to sulfonamides or trimethoprim, as severe allergic reactions can occur. It is also contraindicated in animals with liver damage, blood dyscrasias, or in those with a history of sulfonamide-induced immune disorders.
Due to the complexity of potential drug interactions and the serious nature of some of these interactions, it is crucial for prescribers and patients to provide a complete medication history before starting treatment with sulfadiazine/trimethoprim equine oral liquid. If you have any questions or require further information regarding this formulation and its interactions, please reach out to us at Bayview Pharmacy for professional advice and guidance.
The Sulfadiazine 400 mg/ml/Trimethoprim 80 mg/ml Equine Oral Liquid is a specially compounded medication designed for the treatment of bacterial infections in horses. This formulation combines two antibiotics, sulfadiazine and trimethoprim, which work synergistically to inhibit the growth and multiplication of bacteria. Sulfadiazine is a sulfonamide antibacterial agent that interferes with the synthesis of folic acid in bacteria, which is essential for their growth. Trimethoprim, on the other hand, is a dihydrofolate reductase inhibitor that further blocks the production of tetrahydrofolic acid, another form of folic acid that bacteria require for DNA synthesis and cell division.
This makes the formulation suitable for treating various infections, including respiratory tract infections, urinary tract infections, wound infections, and other systemic infections caused by susceptible bacteria. The liquid dosage form ensures that the medication can be accurately measured and administered, which is especially important for equine patients where dosing precision is critical for therapeutic effectiveness and safety.
The oral liquid formulation is designed to be palatable and easily accepted by horses, which can be a challenge with other dosage forms. It also allows for flexibility in dosing, as the medication can be adjusted according to the weight and severity of the infection in the individual animal. This is particularly beneficial for treating animals that may have difficulty swallowing pills or for those that require a tailored dosing regimen.
For prescribers, it is important to note that the use of this combination should be based on susceptibility testing and should follow veterinary guidelines for antibiotic use. Overuse or misuse of antibiotics can lead to resistance, so it is crucial to use this medication judiciously. For patients, or in this case, the caregivers of the equine patients, adherence to the prescribed dosing schedule is essential for the successful treatment of the infection. It is also important to complete the full course of the medication, even if the animal appears to have recovered, to prevent the development of antibiotic resistance and ensure the infection is fully eradicated.
If you have any questions about the Sulfadiazine/Trimethoprim Equine Oral Liquid or its administration, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the best possible outcomes for your equine patients.
This is a compounded liquid medication specifically designed for oral administration to horses.
The Equine Oral Liquid is commonly prescribed to treat bacterial infections in horses. The combination of Sulfadiazine and Trimethoprim works synergistically to inhibit the growth and spread of bacteria, which can help in treating a wide range of infections caused by susceptible organisms.
The medication should be given orally, following the dosage prescribed by the veterinarian. It can be administered directly using a syringe or added to a small amount of feed if the horse is willing to consume it that way. It is crucial to follow the dosing schedule without missing doses for the treatment to be effective.
No, you should never adjust the dose of medication without the advice of a veterinarian. If a dose is missed, consult with your vet for the appropriate action to take. In many cases, the missed dose should be given as soon as remembered, but not close to the next scheduled dose to avoid doubling up.
While most horses tolerate the medication well, some may experience side effects such as digestive upset, loss of appetite, or allergic reactions. If you notice anything unusual or concerning, contact your veterinarian promptly for advice.
The duration of the treatment will depend on the severity and type of infection, as well as the response of the horse to the medication. It is important to complete the full course of treatment prescribed by the veterinarian, even if the horse appears to be feeling better, to ensure the infection is fully cleared.
The medication can be given with a small amount of feed to facilitate administration. However, some horses may have specific dietary restrictions or conditions that could affect how the medication is given. Always follow the veterinarian's guidance regarding administration with food.
Before administering any other medications or supplements while your horse is taking Sulfadiazine/Trimethoprim Oral Liquid, it is important to consult with your veterinarian as interactions may occur. Your veterinarian will advise you on the safety of combining this medication with others.
The compound should be stored in a cool, dry place, away from sunlight and extreme temperatures. Make sure the bottle is tightly closed and kept out of reach of children and pets. Always check the expiration date and consult with your veterinarian or the pharmacy on proper disposal of expired or unused medication.
If you suspect an overdose has occurred, seek immediate veterinary attention. Symptoms of an overdose may include nausea, vomiting, abdominal pain, or more severe reactions. Quick response to an overdose is crucial for the well-being of your horse.
This particular formulation is designed for equine patients. It should not be administered to other animals unless specifically directed by a veterinarian who has determined it is appropriate for use in another species based on their professional judgment and the needs of the animal.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
